Zurcher Kantonalbank Zurich Cantonalbank Boosts Stake in Health Catalyst, Inc. (NASDAQ:HCAT)

Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Health Catalyst, Inc. (NASDAQ:HCAT) by 23.0% in the 4th quarter, Holdings Channel reports. The fund owned 15,072 shares of the company’s stock after acquiring an additional 2,817 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Health Catalyst were worth $140,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCAT. Impax Asset Management Group plc raised its holdings in Health Catalyst by 52.0% in the fourth quarter. Impax Asset Management Group plc now owns 1,754,475 shares of the company’s stock worth $16,246,000 after purchasing an additional 600,000 shares in the last quarter. Primecap Management Co. CA increased its stake in shares of Health Catalyst by 86.3% in the 3rd quarter. Primecap Management Co. CA now owns 1,120,438 shares of the company’s stock worth $11,339,000 after acquiring an additional 519,004 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Health Catalyst by 124.0% in the 3rd quarter. Bank of New York Mellon Corp now owns 854,896 shares of the company’s stock worth $8,652,000 after acquiring an additional 473,323 shares in the last quarter. Nepsis Inc. lifted its position in Health Catalyst by 20.5% during the 4th quarter. Nepsis Inc. now owns 1,091,932 shares of the company’s stock valued at $10,111,000 after acquiring an additional 186,128 shares during the period. Finally, Trexquant Investment LP boosted its stake in Health Catalyst by 403.5% during the third quarter. Trexquant Investment LP now owns 141,531 shares of the company’s stock worth $1,432,000 after acquiring an additional 113,423 shares in the last quarter. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HCAT shares. Canaccord Genuity Group decreased their target price on shares of Health Catalyst from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Friday, February 23rd. Piper Sandler reissued an “overweight” rating and issued a $15.00 target price (down from $17.00) on shares of Health Catalyst in a report on Friday, February 23rd. Guggenheim upgraded Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price target for the company in a report on Friday, January 26th. KeyCorp reiterated a “sector weight” rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $16.00 price objective on shares of Health Catalyst in a research note on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Health Catalyst presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.10.

Health Catalyst Price Performance

Shares of NASDAQ:HCAT opened at $6.65 on Thursday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 4.42 and a current ratio of 4.42. The firm has a market cap of $392.55 million, a price-to-earnings ratio of -3.17 and a beta of 1.32. The business has a 50-day simple moving average of $7.08 and a two-hundred day simple moving average of $8.16. Health Catalyst, Inc. has a fifty-two week low of $5.45 and a fifty-two week high of $14.37.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.06. Health Catalyst had a negative net margin of 39.92% and a negative return on equity of 12.19%. The firm had revenue of $75.08 million during the quarter, compared to analysts’ expectations of $73.67 million. On average, analysts expect that Health Catalyst, Inc. will post -0.47 earnings per share for the current year.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.